MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastoma
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-07-13
DOI
10.1093/hmg/ddab201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
- (2019) Tanvi Sharma et al. ACTA NEUROPATHOLOGICA
- Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
- (2019) Harish Shrikrishna Bharambe et al. Acta Neuropathologica Communications
- Resolving medulloblastoma cellular architecture by single-cell genomics
- (2019) Volker Hovestadt et al. NATURE
- Medulloblastoma in the age of molecular subgroups: a review
- (2019) Kyle Juraschka et al. Journal of Neurosurgery-Pediatrics
- MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2
- (2018) Yu He et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- DEPTOR at the Nexus of Cancer, Metabolism, and Immunity
- (2018) Alexandre Caron et al. PHYSIOLOGICAL REVIEWS
- Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
- (2018) Antoine Forget et al. CANCER CELL
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
- (2018) Tenley C. Archer et al. CANCER CELL
- MiR-592 suppresses the development of glioma by regulating Rho-associated protein kinase
- (2018) Shanshan Gao et al. NEUROREPORT
- EML proteins in microtubule regulation and human disease
- (2016) Andrew M. Fry et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A)
- (2016) Qi Fu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- In vitro models of medulloblastoma: Choosing the right tool for the job
- (2016) Delyan P. Ivanov et al. JOURNAL OF BIOTECHNOLOGY
- DEPTOR Is a Stemness Factor That Regulates Pluripotency of Embryonic Stem Cells
- (2014) Pooja Agrawal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutations in Eml1 lead to ectopic progenitors and neuronal heterotopia in mouse and human
- (2014) Michel Kielar et al. NATURE NEUROSCIENCE
- Driving neural regeneration through the mammalian target of rapamycin
- (2014) Kenneth Maiese Neural Regeneration Research
- Novel Cerebellum-Enriched miR-592 May Play a Role in Neural Progenitor Cell Differentiation and Neuronal Maturation Through Regulating Lrrc4c and Nfasc in Rat
- (2013) J. Zhang et al. CURRENT MOLECULAR MEDICINE
- Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas
- (2013) Ratika Kunder et al. NEURO-ONCOLOGY
- HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
- (2012) Till Milde et al. JOURNAL OF NEURO-ONCOLOGY
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway
- (2011) NeelamVishwanath Shirsat et al. Journal of Cancer Research and Therapeutics
- Deletion of ERK1 and ERK2 in the CNS Causes Cortical Abnormalities and Neonatal Lethality: Erk1 Deficiency Enhances the Impairment of Neurogenesis in Erk2-Deficient Mice
- (2011) Y. Satoh et al. JOURNAL OF NEUROSCIENCE
- mTOR-Mediated Activation of p70 S6K Induces Differentiation of Pluripotent Human Embryonic Stem Cells
- (2010) Charles A. Easley et al. Cellular Reprogramming
- ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration
- (2010) Liangping Yuan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation
- (2009) W. A. Tyler et al. JOURNAL OF NEUROSCIENCE
- Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
- (2008) A. Toschi et al. MOLECULAR AND CELLULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started